Anzeige
Mehr »
Mittwoch, 24.06.2026 - Börsentäglich über 12.000 News
Schuldenfrei, 1,5 Mio. Unzen Gold und Produktion ab 2027: Vor dem Ausbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JDMF | ISIN: US75062E1064 | Ticker-Symbol:
NASDAQ
23.06.26 | 21:55
2,660 US-Dollar
-2,21 % -0,060
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
RAFAEL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
RAFAEL HOLDINGS INC 5-Tage-Chart

Aktuelle News zur RAFAEL HOLDINGS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.06.Rafael Holdings, Inc. - 10-Q, Quarterly Report3
11.06.Rafael Holdings GAAP EPS of -$0.08, revenue of $0.18M2
11.06.Rafael Holdings, Inc.: Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results197NEWARK, N.J., June 11, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the third quarter fiscal year 2026 ended April 30, 2026. "Yesterday, we were...
► Artikel lesen
RAFAEL HOLDINGS Aktie jetzt für 0€ handeln
10.06.Rafael Holdings, Inc. - 8-K, Current Report1
10.06.Rafael Holdings schließt Patientenrekrutierung für Phase-3-Studie ab - Aktie legt deutlich zu4
10.06.Rafael Holdings completes phase 3 NPC disease trial enrollment2
10.06.Rafael Holdings, Inc.: Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C229Topline results are expected to be announced in second half of calendar 2026 The company has had a pre-NDA meeting with the FDA and expects to submit an NDA in second half of calendar 2026 The company...
► Artikel lesen
22.04.Rafael Holdings, Inc.: Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease"1
22.04.Rafael Holdings, Inc. - 8-K, Current Report-
16.03.Rafael Holdings GAAP EPS of -$0.131
16.03.Rafael Holdings, Inc. - 10-Q, Quarterly Report3
16.03.Rafael Holdings, Inc. - 8-K, Current Report2
16.03.Rafael Holdings, Inc.: Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results277NEWARK, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the second quarter fiscal year 2026 ended January 31, 2026. "We remain pleased...
► Artikel lesen
27.01.Rafael Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans3
11.12.25Rafael Holdings, Inc.: Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results442NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025. "We remain pleased...
► Artikel lesen
29.10.25Rafael Holdings, Inc.: Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results376Cyclo Therapeutics' TransportNPC Phase 3 clinical trial for Trappsol® Cyclo for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation...
► Artikel lesen
28.10.25Rafael Holdings, Inc.: Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors256NEWARK, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) sadly announced today the passing of its Lead Independent Director, Stephen Greenberg, and...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1